Genesem Inc. (KOSDAQ:217190)
8,340.00
+220.00 (2.71%)
At close: Oct 23, 2026
| Market Cap | 109.70B +39.1% |
| Revenue (ttm) | 59.78B +5.4% |
| Net Income | 187.99M -89.2% |
| EPS | 14.29 -89.2% |
| Shares Out | 13.15M |
| PE Ratio | 583.55 |
| Forward PE | n/a |
| Dividend | 50.00 (0.60%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 210,856 |
| Open | 7,900.00 |
| Previous Close | 8,120.00 |
| Day's Range | 7,490.00 - 8,510.00 |
| 52-Week Range | 3,965.00 - 10,650.00 |
| Beta | 1.27 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |